ArticleCureus2025
Tiny Joints, Big Clues: Neonatal Septic Polyarthritis as a Rare Presentation of Late-Onset Streptococcus agalactiae Sepsis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Late-onset group B streptococcal septic arthritis in an afebrile neonate: a case report.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Group B Streptococcus (GBS), or Streptococcus agalactiae, is a significant cause of neonatal morbidity and mortality, with late-onset disease (LOGBS) typically manifesting as bacteremia or meningitis. Osteoarticular infections, particularly septic polyarthritis, are exceedingly rare but potentially devastating complications of LOGBS. We report a rare case of LOGBS presenting as septic polyarthritis in a 28-day-old term male neonate. The infant presented with a 15-day history of progressive swelling in the left knee and right shoulder, accompanied by irritability and feeding difficulties. Ultrasonography revealed joint effusions, and aspiration yielded Gram-positive cocci in chains. Culture confirmed S. agalactiae, susceptible to ceftriaxone and vancomycin but resistant to multiple other antibiotics. Targeted antibiotic therapy was initiated, and surgical drainage of both joints was performed. The infant responded well, with complete clinical recovery. Immunophenotyping revealed reduced B-lymphocyte levels, suggesting a potential underlying immune vulnerability. This case underscores the importance of recognizing atypical manifestations of GBS in neonates. Prompt microbiological diagnosis using Gram stain and culture, combined with susceptibility-guided antimicrobial therapy and early surgical intervention, was instrumental in achieving a favorable outcome. The lymphocyte subset abnormality raises the possibility of an underlying immune dysfunction, warranting further follow-up. In regions without routine GBS screening, clinicians must maintain a high index of suspicion for uncommon presentations like septic polyarthritis. Early recognition, multidisciplinary management, and individualized therapy are key to optimizing outcomes in such rare neonatal infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.